Sector consensus Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
02:29:02 13/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 301.34 USD | -0.21% |
|
+3.99% | +51.24% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 190.75 | +20.88% | 17 | ||||||
| 1,135.7 | +39.25% | 15 | ||||||
| 689.48 | +20.5% | 23 | ||||||
| 295.05 | +13.53% | 19 | ||||||
| 259.14 | +36.56% | 23 | ||||||
| 435.53 | +22.87% | 27 | ||||||
| 267,741.48 | +49.08% | 22 | ||||||
| 50.74 | +10.4% | 23 | ||||||
| 103.71 | +19.76% | 20 | ||||||
| 197.74 | +96.56% | 23 | ||||||
| 2,592.46 | +6.03% | 15 | ||||||
| 595.92 | -2.63% | 13 | ||||||
| 1,482.61 | +24.07% | 8 | ||||||
| 274.28 | +33.97% | 20 | ||||||
| 72.29 | -6.26% | 14 | ||||||
| 54.87 | -8.34% | 15 | ||||||
| 310.53 | +2.9% | 15 | ||||||
| 22.51 | +69.17% | 13 | ||||||
| 619.67 | +39.38% | 19 | ||||||
| Average | 14,585.5 | +25.67% | 18 | ||||||
| Weighted average by Cap. | 15,654.16 | +26.21% | 19 |
Select your edition
All financial news and data tailored to specific country editions
